Alkermes logo

Alkermes

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Flexible Media Releases

Alkermes Celebrates Mental Health Month

Campaigns

Alkermes: Corporate Responsibility
We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...

Alkermes: Diversity, Inclusion & Belonging
Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...

Alkermes Medicines & Focus: Serious Mental Illness
We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...

Alkermes Medicines & Focus: Cancer
We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...

Alkermes Inspiration Grants®
Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive...

Alkermes Medicines & Focus: Addiction
We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...

Videos

Contact Alkermes
open_in_new